-
1
-
-
0025001892
-
Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium
-
Zsebo KM, Wypych J, McNiece IK et al. Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 1990; 63: 195-201.
-
(1990)
Cell
, vol.63
, pp. 195-201
-
-
Zsebo, K.M.1
Wypych, J.2
McNiece, I.K.3
-
2
-
-
0025828970
-
Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter
-
Geissler EN, Liao M, Brook JD et al. Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somat Cell Mol Genet 1991; 17: 207-14.
-
(1991)
Somat Cell Mol Genet
, vol.17
, pp. 207-214
-
-
Geissler, E.N.1
Liao, M.2
Brook, J.D.3
-
3
-
-
15644363454
-
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
-
Hirota S, Isozaki K, Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-80.
-
(1998)
Science
, vol.279
, pp. 577-580
-
-
Hirota, S.1
Isozaki, K.2
Moriyama, Y.3
-
4
-
-
0035890740
-
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors
-
Rubin BP, Singer S, Tsao C et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 2001; 61: 8118-21.
-
(2001)
Cancer Res
, vol.61
, pp. 8118-8121
-
-
Rubin, B.P.1
Singer, S.2
Tsao, C.3
-
5
-
-
0035810147
-
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
-
Druker BJ, Talpaz M, Resta DJ et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031-7.
-
(2001)
N Engl J Med
, vol.344
, pp. 1031-1037
-
-
Druker, B.J.1
Talpaz, M.2
Resta, D.J.3
-
6
-
-
0037103424
-
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
-
Demetri GD, von Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472-80.
-
(2002)
N Engl J Med
, vol.347
, pp. 472-480
-
-
Demetri, G.D.1
von Mehren, M.2
Blanke, C.D.3
-
7
-
-
27644580756
-
Imatinib is not a potential alternative treatment for uterine leiomyosarcoma
-
Serrano C, Mackintosh C, Herrero D et al. Imatinib is not a potential alternative treatment for uterine leiomyosarcoma. Clin Cancer Res 2005; 11: 4977-9.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4977-4979
-
-
Serrano, C.1
Mackintosh, C.2
Herrero, D.3
-
8
-
-
16344378795
-
Lack of response to imatinib mesylate as second-line therapy in a patient with c-kit positive metastatic soft tissue leiomyosarcoma
-
Silvestris N, Parra HS, Angelini F, Di Cosimo S, D'Aprile M, Santoro A. Lack of response to imatinib mesylate as second-line therapy in a patient with c-kit positive metastatic soft tissue leiomyosarcoma. Tumori 2005; 91: 103.
-
(2005)
Tumori
, vol.91
, pp. 103
-
-
Silvestris, N.1
Parra, H.S.2
Angelini, F.3
Di Cosimo, S.4
D'Aprile, M.5
Santoro, A.6
-
9
-
-
1842583423
-
Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunohistochemical C-KIT (CD117): Preliminary results of a compassionate use clinical trial
-
Fiorentini G, Rossi S, Lanzanova G et al. Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunohistochemical C-KIT (CD117): Preliminary results of a compassionate use clinical trial. J Exp Clin Cancer Res 2003; 22: 17-20.
-
(2003)
J Exp Clin Cancer Res
, vol.22
, pp. 17-20
-
-
Fiorentini, G.1
Rossi, S.2
Lanzanova, G.3
-
10
-
-
0035142836
-
Gastrointestinal stromal tumors: Definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis
-
Miettinen M, Lasota J. Gastrointestinal stromal tumors: Definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12.
-
(2001)
Virchows Arch
, vol.438
, pp. 1-12
-
-
Miettinen, M.1
Lasota, J.2
-
11
-
-
0036301722
-
Diagnosis of gastrointestinal stromal tumors: A consensus approach
-
Fletcher CD, Berman JJ, Corless C et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-65.
-
(2002)
Hum Pathol
, vol.33
, pp. 459-465
-
-
Fletcher, C.D.1
Berman, J.J.2
Corless, C.3
-
12
-
-
0036319991
-
Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution
-
Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002; 117: 188-93.
-
(2002)
Am J Clin Pathol
, vol.117
, pp. 188-193
-
-
Hornick, J.L.1
Fletcher, C.D.2
-
13
-
-
4544285577
-
Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis
-
Yamaguchi U, Hasegawa T, Masuda T et al. Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch 2004; 445: 142-50.
-
(2004)
Virchows Arch
, vol.445
, pp. 142-150
-
-
Yamaguchi, U.1
Hasegawa, T.2
Masuda, T.3
-
14
-
-
0037344905
-
The problem with KIT: Clinical implications and practical difficulties with CD117 immunostaining
-
Sabah M, Leader M, Kay E. The problem with KIT: Clinical implications and practical difficulties with CD117 immunostaining. Appl Immunohistochem Mol Morphol 2003; 11: 56-61.
-
(2003)
Appl Immunohistochem Mol Morphol
, vol.11
, pp. 56-61
-
-
Sabah, M.1
Leader, M.2
Kay, E.3
-
15
-
-
0037365824
-
c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies
-
Lucas DR, al-Abbadi M, Tabaczka P, Hamre MR, Weaver DW, Mott MJ. c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol 2003; 119: 339-45.
-
(2003)
Am J Clin Pathol
, vol.119
, pp. 339-345
-
-
Lucas, D.R.1
al-Abbadi, M.2
Tabaczka, P.3
Hamre, M.R.4
Weaver, D.W.5
Mott, M.J.6
-
16
-
-
4344712342
-
Expression of c-kit in Ewing family of tumors: A comparison of different immunohistochemical protocols
-
Ahmed A, Gilbert-Barness E, Lacson A. Expression of c-kit in Ewing family of tumors: A comparison of different immunohistochemical protocols. Pediatr Dev Pathol 2004; 7: 342-7.
-
(2004)
Pediatr Dev Pathol
, vol.7
, pp. 342-347
-
-
Ahmed, A.1
Gilbert-Barness, E.2
Lacson, A.3
-
17
-
-
5444222014
-
Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: A subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene
-
Sakurai S, Hasegawa T, Sakuma Y et al. Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: A subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Hum Pathol 2004; 35: 1223-30.
-
(2004)
Hum Pathol
, vol.35
, pp. 1223-1230
-
-
Sakurai, S.1
Hasegawa, T.2
Sakuma, Y.3
-
18
-
-
0023039303
-
The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining
-
Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 1986; 125: 431-5.
-
(1986)
Am J Pathol
, vol.125
, pp. 431-435
-
-
Sato, Y.1
Mukai, K.2
Watanabe, S.3
Goto, M.4
Shimosato, Y.5
-
19
-
-
0032950650
-
Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal
-
Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol 1999; 154: 23-8.
-
(1999)
Am J Pathol
, vol.154
, pp. 23-28
-
-
Sakurai, S.1
Fukasawa, T.2
Chong, J.M.3
Tanaka, A.4
Fukayama, M.5
-
20
-
-
30344468474
-
Gastrointestinal sarcoma (GIST): A review of surgical management
-
Lehnert T. Gastrointestinal sarcoma (GIST): A review of surgical management. Ann Chir Gynaecol 1998; 87: 297-305.
-
(1998)
Ann Chir Gynaecol
, vol.87
, pp. 297-305
-
-
Lehnert, T.1
-
21
-
-
0035421175
-
Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis
-
Sjoblom T, Shimizu A, O'Brien KP et al. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res 2001; 61: 5778-83.
-
(2001)
Cancer Res
, vol.61
, pp. 5778-5783
-
-
Sjoblom, T.1
Shimizu, A.2
O'Brien, K.P.3
-
22
-
-
2542477282
-
Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody
-
Cheuk W, Wong KO, Wong CS, Chan JK. Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody. Am J Surg Pathol 2004; 28: 801-7.
-
(2004)
Am J Surg Pathol
, vol.28
, pp. 801-807
-
-
Cheuk, W.1
Wong, K.O.2
Wong, C.S.3
Chan, J.K.4
-
23
-
-
23044465978
-
Rabbit monoclonal antibodies: A comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies
-
Rossi S, Laurino L, Furlanetto A et al. Rabbit monoclonal antibodies: A comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. Am J Clin Pathol 2005; 124: 295-302.
-
(2005)
Am J Clin Pathol
, vol.124
, pp. 295-302
-
-
Rossi, S.1
Laurino, L.2
Furlanetto, A.3
|